Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	944,529 L.L
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	1,416,794 L.L
J05AF05	VICONDINE	G	Lamivudine - 150mg	150mg	Tablet, film coated	3,573,725 L.L
D02AC	VASIDEX	G	Vaseline pure - 15g	15g	Ointment	78,071 L.L
J07BB01	VAXIGRIP	B	Influenza vaccine virus inactivated - 15mcg/3strains/0.5ml	15mcg/3strains/0.5ml	Injectable suspension	768,678 L.L
B01AF01	VAROXA	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
C09CA03	VALSANET	G	Valsartan - 160mg	160mg	Tablet, film coated	560,574 L.L
C09CA03	VALSARTAN ARROW LAB	G	Valsartan - 160mg	160mg	Tablet, film coated, breakable	473,033 L.L
C09CA03	VALUSTAR	G	Valsartan - 160mg	160mg	Tablet, film coated	634,294 L.L
C09CA03	VIOSTAN 160	G	Valsartan - 160mg	160mg	Tablet, film coated	668,082 L.L
A04AA01	VOMITRON	G	Ondansetron - 16mg	16mg	Suppository	578,492 L.L
A04AA01	VOMITRON	G	Ondansetron - 16mg	16mg	Suppository	304,604 L.L
N07CA01	VASOSERC FORTE	G	Betahistine dihydrochloride - 16mg	16mg	Tablet	944,529 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	1,204,339 L.L
N07CA01	VERTINEX	G	Betahistine dihydrochloride - 16mg	16mg	Tablet	371,157 L.L
C10AX06	VASCEPA	B	Eicosapentaenoic acid (Ethyl ester) - 1g	1g	Capsule	21,464,912 L.L
J01XA01	VANCO MEDIS	G	Vancomycin - 1g	1g	Injectable lyophilisate for solution	1,276,650 L.L
J01DD04	VERACOL	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	454,219 L.L
P02CB01	VERMIFUGE	G	Piperazine citrate - 1g/5ml	1g/5ml	Syrup	148,463 L.L
L02BG03	VICTEVE	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,151,673 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 2%	2%	Gel	588,603 L.L
B05AA01	VIALEBEX	BioHuman	Albumin human - 200g/L	200g/L	Injectable solution	3,417,391 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 200mg	200mg	Capsule	976,973 L.L
N03AX18	VIMPAT	B	Lacosamide - 200mg	200mg	Tablet, film coated	13,357,859 L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 200mg	200mg	Tablet, film coated	31,567,504 L.L
J02AC03	VFEND	B	Voriconazole - 200mg	200mg	Tablet, film coated	51,904,550 L.L
J02AC03	VIROZOLE 200	G	Voriconazole - 200mg	200mg	Tablet, film coated	47,909,207 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Tablet, coated	41,794,841 L.L
J02AC03	V-FEND	B	Voriconazole - 200mg	200mg	Injectable powder for solution	8,078,564 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Injectable powder for solution	5,841,683 L.L

...